<document xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:z="http://www.ebi.ac.uk/z" source="Whatizit"><text><SENT sid="0" pm="."><plain>We retrospectively studied a large cohort of patients with <z:e sem="disease" ids="C0409980" disease_type="Disease or Syndrome" abbrv="">primary antiphospholipid syndrome</z:e> (APS) from 4 different referral centers to analyze the clinical and serologic features and, specifically, to determine the number of patients going on to develop <z:hpo ids='HP_0002725'>systemic lupus erythematosus</z:hpo> (SLE) or other <z:hpo ids='HP_0002960'>autoimmune disease</z:hpo> after long-term follow-up </plain></SENT>
<SENT sid="1" pm="."><plain>The study included 128 unselected patients with primary APS who fulfilled the Sapporo International Criteria from 4 different tertiary hospitals in the United Kingdom, Mexico, and Spain </plain></SENT>
<SENT sid="2" pm="."><plain>The patients had attended the referral centers between January 1987 and July 2001 </plain></SENT>
<SENT sid="3" pm="."><plain>We reviewed clinical and serologic characteristics according to a pre-established protocol </plain></SENT>
<SENT sid="4" pm="."><plain>We used univariate analysis with the chi-squared or Fisher exact test and logistic regression to analyze possible factors related to the coexistence of SLE and APS </plain></SENT>
<SENT sid="5" pm="."><plain>Ninety-seven female and 31 male patients fulfilled the criteria, with a median age of 42 +/- 12 years (range, 16-79 yr), and with a mean follow-up of 9 +/- 3 years (range, 2-15 yr) </plain></SENT>
<SENT sid="6" pm="."><plain>The main manifestations included <z:hpo ids='HP_0002625'>deep vein thrombosis</z:hpo> in 62 patients (48%), <z:hpo ids='HP_0004420'>arterial thrombosis</z:hpo> in 63 (49%) patients, pregnancy loss in 177/320 (55%) cases, and <z:hpo ids='HP_0002204'>pulmonary embolism</z:hpo> in 37 (30%) patients </plain></SENT>
<SENT sid="7" pm="."><plain>Other clinical manifestations were <z:hpo ids='HP_0002076'>migraine</z:hpo> in 51 (40%) patients, <z:hpo ids='HP_0001873'>thrombocytopenia</z:hpo> in 48 (38%), <z:hpo ids='HP_0000965'>livedo reticularis</z:hpo> in 47 (37%), and valvular disease in 27 (21%) </plain></SENT>
<SENT sid="8" pm="."><plain>Serologic findings were anticardiolipin antibodies (aCL) IgG positive in 110 (86%) patients, aCL IgM in 36 (39%), <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e> <z:chebi fb="3" ids="50249">anticoagulant</z:chebi> in 71 (65%), <z:hpo ids='HP_0003493'>antinuclear antibodies</z:hpo> in 47 (37%), and positive Coombs test in 5 (4%) patients </plain></SENT>
<SENT sid="9" pm="."><plain>During the follow-up and after a median disease duration of 8.2 years (range, 1-14 yr), 11 (8%) patients developed SLE, 6 (5%) developed <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease, and 1 (1%) developed <z:hpo ids='HP_0003473'>myasthenia</z:hpo> gravis </plain></SENT>
<SENT sid="10" pm="."><plain>The remaining 110 patients (86%) continued to have primary APS </plain></SENT>
<SENT sid="11" pm="."><plain>After the univariate analysis, a family history of <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>, the presence of <z:e sem="disease" ids="C0034735" disease_type="Disease or Syndrome" abbrv="">Raynaud phenomenon</z:e>, <z:hpo ids='HP_0002076'>migraine</z:hpo>, psychiatric features, multiple <z:mp ids='MP_0000612'>sclerosis</z:mp>-like features, <z:hpo ids='HP_0001878'>hemolytic anemia</z:hpo>, low C3 and C4, and Coombs positivity conferred a statistically significant risk for the subsequent development of SLE (p &lt; 0.05) </plain></SENT>
<SENT sid="12" pm="."><plain>Only the presence of Coombs positivity had statistical significance (odds ratio, 66.4; 95% confidence interval, 1.6-2714; p = 0.027) after the logistic regression evaluation </plain></SENT>
<SENT sid="13" pm="."><plain>The current study confirms that progression from primary APS to SLE or <z:e sem="disease" ids="C0024138,C0024141,C0024131,C0409974" disease_type="Disease or Syndrome" abbrv="">lupus</z:e>-like disease is unusual, even after a long follow-up </plain></SENT>
<SENT sid="14" pm="."><plain>Only 3 patients developed anti-dsDNA antibodies </plain></SENT>
<SENT sid="15" pm="."><plain>The presence of a positive Coombs test might be a marker for the development of SLE in patients with primary APS </plain></SENT>
</text></document>